IL6 and systemic lupus erythematosus: Cytokine blockade targeting TNF-α and IL-6, have been successfully developed to treat rheumatoid arthritis, while barely any anti-cytokine therapies have been successfully introduced into clinical practice as drugs for SLE patients.